Health Trials

POLE Exonuclease Domain Mutation

1

Review clinical trials related to POLE Exonuclease Domain Mutation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Cohort of Tumors With POLE/D1 Mutation

Primary objective of this study is to identify and describe the clinico-biological and molecular characteristics of tumors with somatic POLE (Polymerase ɛ)/POLD1 mutation identified by molecular biology platforms for all stages and primary sites combined

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Federation Francophone de Cancerologie DigestiveUpdated: Jul 8, 2024Locations: 1
Eligibility criteria

Any tumor presenting a variant of the exonuclease domain of POLE (exons 9 to 14)... [+1]

Tumor without POLE or POLD1 mutation [+2]

Read more